Subject: 2015-16 Induced Pluripotent Stem Cell Report

Hey,

I know that many of you work with induced pluripotent stem cells (iPSCs), developing research tools, investigating therapies, or operating a stem cell bank. 

For this reason, I wanted to share with you that the "Complete 2015-16 Induced Pluripotent Stem Cell Industry Report" was just released.........

AND.........

We are offering it for "40% Off" as a one-time launch special to only the first 25 people that claim it. 


Learn about: 

1.  1st Clinical Trial in Humans: iPSCs Tested for Restoring Eyesight
2   A Historic iPSC Patent Dispute 
3.  Competitive Environment for iPSC Products
4.  Size of the iPSC Market and Projections through 2020
5.  iPSC Funding Momentum: Grant Awards, Stock Offerings, and Acquisitions
6.  Trend Rate Data for Clinical Trials, Scientific Publications, and Grants
7.  Key iPSC Patents, Inventors, and Assignees
8.  Geographical Clustering of iPSC Research Activity
9.  Strategic Alliances and Partnerships
10. Survey Results from iPSC Researchers (131 U.S. / 143 International)


We will never offer this pricing again, so use the code "Launch40" to claim 40% off.............

Before the 25 units are no longer available. 


Link to report:
http://www.bioinformant.com/product/complete-2015-16-induced-pluripotent-stem-cell-ipsc-industry-report/


To Your Success,
Cade
President/CEO of BioInformant


p.s. If you have questions about iPSCs or this report, email me at Hildreth@BioInformant.com and I'll get right back to you.
BIOINFORMANT | 800 Corporate Drive, Suite 301, Stafford, VA 22554, United States
You may unsubscribe or change your contact details at any time.

    This is an online snapshot of a newsletter created by the owner of BioInformant Worldwide, LLC | Stem Cell Industry Data (BioInformant.com, BIOINFORMANT | 800 Corporate Drive, Suite 301, 22554 Stafford) and sent via GetResponse on 2015-05-27. Report abuse